Concepedia

Arnon I. Dreyfuss

AI

11

Publications

858

Citations

11

H-Index

1984

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Arnon I. Dreyfuss is an author at Dana-Farber Cancer Institute specializing in cancer research, radiation oncology, and medicine.

Top concepts

Publications per year

1984–1998

11

Publications

11

Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

Arnon I. Dreyfuss, J. Clark, Charles M. Norris et al. · Journal of Clinical Oncology · 1996 · 233 citations

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

Arnon I. Dreyfuss, John R. Clark, Barbara G. Fallon et al. · Cancer · 1987 · 153 citations · Full text

, , +19

Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck

Arnon I. Dreyfuss · Annals of Internal Medicine · 1990 · 125 citations

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.

A. Dimitrios Colevas, Paul M. Busse, Charles M. Norris et al. · Journal of Clinical Oncology · 1998 · 113 citations

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.

J. Clark, Paul M. Busse, Charles M. Norris et al. · Journal of Clinical Oncology · 1997 · 60 citations

Rows per page

1–5 of 11